An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stabilityZsuzsanna Nagy, Glenn M. Marshall|Nature Communications|2021Cited by 87
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cellsGlenn M. Marshall, Belamy B. Cheung|Oncogene|2010Cited by 70
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentSusan L. Heatley, Deborah L. White, Timothy P. Hughes et al.|Haematologica|2017Cited by 62
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis <i>in vivo</i> and reduces skin cancer cell migration <i>in vitro</i>Belamy B. Cheung, Glenn M. Marshall|The Journal of Pathology|2011Cited by 39
Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B. Cheung, Glenn M. Marshall|Molecular Oncology|2015Cited by 17